Skip to main content
. 2012 Dec 18;24(8):615–624. doi: 10.3109/09537104.2012.748185

Figure 3.

Figure 3.

Inhibition of platelet aggregation (final-extent, 20 µM ADP-induced) following administration of ticagrelor (a) 50 mg bid for 5 days, and (b) 200 mg bid for 4 days then qd for 1 day, ± once-daily aspirin (300 mg) (Study A). Values are mean ± SD, n = 11 or 12 at each time point.